Introduction
============

Intestinal inflammation either in human beings or in experimental animal models is associated with altered gastrointestinal motility \[[@b1]--[@b3]\]. The mechanisms of altered motility have been associated with morphological and functional changes in smooth muscle and enteric nerves \[[@b4]--[@b6]\]. Large numbers of polymorphonuclear leucocytes that generate reactive oxygen species (ROS) such as H~2~O~2~ are found in the mucosa and submucosa of the inflamed bowel disease, suggesting that H~2~O~2~ plays an integral role in the inflammatory process \[[@b7]\]. Several *in vitro* studies have reported that exposure to H~2~O~2~ alters gastrointestinal smooth muscle contractility. For example, H~2~O~2~ decreases sigmoid smooth muscle contractility in ulcerative colitis patients and the radical scavenger catalase prevents ulcerative colitis-induced reduction of muscle contractions \[[@b8], [@b9]\]. Exposure to H~2~O~2~ reduces the lower esophageal sphincter tone in human esophagitis and treatment with catalase can restore the lower esophageal tone to normal \[[@b10]\]. From above findings, it is suggested that H~2~O~2~ may be an important mediator causing dysmotility in intestinal inflammation.

The gastrointestinal smooth muscles show spontaneous mechanical contractions. These contractions are mediated by the generation of periodic membrane depolarization (slow waves). It is well known that interstitial cells of Cajal (ICC) are pacemaker cells that generate slow waves, which are initiated by spontaneous inward currents (pacemaker currents) \[[@b11]--[@b13]\], even if some reports suggested that gastrointestinal pacing was possible without ICC and other pacemaker cells may be involved in pacing activity \[[@b14], [@b15]\]. ICC are coupled to each other and to smooth muscle cells *via* gap junctions. ICC also express various receptors for receiving inhibitory and excitatory signals from the enteric nervous systems \[[@b16], [@b17]\]. Acetic acid-induced inflammation reduces the membrane potential and reduces the amplitude and duration of slow waves in colonic circular muscle cells, suggesting that ICC may involve in motility changes in the inflammatory process \[[@b18]\].

Despite the observation that H~2~O~2~ is involved in intestinal motility through the changes of smooth muscle contractility, ion channel activity and enteric neuronal mechanisms, there are no reports describing the modulatory effects of H~2~O~2~ on pacemaker activities of ICC. In the present study, we investigated the effects of H~2~O~2~ on pacemaker currents and signal transductions to determine whether the intestinal motility can be modulated by ROS through ICC in the murine intestine.

Materials and methods
=====================

Preparation of cells and tissues
--------------------------------

Balb/C mice (8- to 13-day old) of either sex were anaesthetized with ether and killed by cervical dislocation. The small intestines from 1 cm below the pyloric ring to the cecum were removed and opened along the mesenteric border. The luminal contents were washed away with Krebs-Ringer bicarbonate solution. The tissues were pinned to the base of a Sylgard dish and the mucosa was removed by sharp dissection. Small stripes of intestinal muscle were equilibrated in Ca^2+^-free Hank's solution for 30 min and the cells were dispersed with an enzyme solution containing collagenase (Worthington Biochemical Co, Lakewood, NJ, USA), 1.3 mg/ml, bovine serum albumin (Sigma Chemical Co., St. Louis, MO, USA), 2 mg/ml, trypsin inhibitor (Sigma), 2 mg/ml and ATP, 0.27 mg/ml. Cells were plated onto sterile glass coverslips coated with murine collagen (2.5 μg/ml, Falcon/BD) in 35-mm culture dishes. The cells were then cultured at 37°C in a 95% O~2~--5% CO~2~ incubator in SMGM (smooth muscle growth medium, Clonetics Corp., San Diego, CA, USA) supplemented with 2% antibiotics/antimycotics (Gibco, Grand Island, NY, USA) and 5 ng/ml murine stem cell factor (SCF, Sigma).

Patch-clamp experiments
-----------------------

Cultures of cells contained single cells and networks of cells that had gross morphological properties similar to ICC *in situ,* including fusiform cell bodies, large, prominent nuclei with little perinuclear cytoplasm and multiple, thin processes extending from the nuclear region that were often interconnected with processes of neighbouring cells \[[@b19]\]. Recordings were made from ICC with the patch-clamp technique as soon as the network-like structures. Recordings were made from cells within networks that had morphologies similar to the cells that were immunopositive for c-Kit.

The whole-cell configuration of the patch-clamp technique was used to record membrane currents (voltage clamp) and membrane potentials (current clamp) from cultured ICC. Currents or potentials were amplified by use of an Axopatch 1-D (Axon Instruments, Foster City, CA, USA). Command pulse was applied using an IBM-compatible personal computer and pClamp software (version 6.1; Axon Instruments). The data were filtered at 5 kHz and displayed on a computer monitor, and a pen recorder (Gould 2200, Gould, Valley view, OH, USA). All experiments were performed at 30°C.

Results were analysed using pClamp and Graph Pad Prizem (version 2.01) software.

Protein tyrosine kinase assays using adenoviral vectors
-------------------------------------------------------

Adenoviral vectors encoding enhanced green fluorescent fusion proteins were generated by the two-plasmid rescue system. The following scheme shows a typical protocol for the adenoviral vector assay in live cells using adenoviral vector transduction.

Day 1: Seed appropriate ICC in culture medium with the adenoviral vector at a predetermined multiplicity of infection (MOI) and incubate for 24 hrs

Day 2: H~2~O~2~ compounds are added to the incubated samples and the samples are allowed to incubate at 37°C. After incubation, the nuclei of ICC are stained using 2.5 μM Hoechst stain.

Image acquisition (EGFP redistribution assays) was performed on a confocal microscope (×100; fluoviews 300, Olympus) using 360/40 nm (HoechstTM) and 475/20 nm (EGFP) excitation filters and a 535/20 nm emission filter.

Solutions and drugs
-------------------

The cells were bathed in a solution containing 5 mm KCl, 135 mm NaCl, 2 mm CaCl~2~, 10 mm glucose, 1.2 mm MgCl~2~ and 10 mm HEPES, adjusted to pH 7.2 with Tris. The pipette solution contained 140 mm KCl, 5 mm MgCl~2~, 2.7 mm K~2~ATP, 0.1 mm Na~2~GTP, 2.5 mm creatine phosphate disodium, 5 mm HEPES, 0.1 mm EGTA, adjusted to pH 7.2 with Tris.

The drugs used were: hydrogen peroxide, catalase, SC560, AACOCF~3~, AH6809, glibenclamide, PD98059, SB203580, SQ-22536, JNK inhibitor, NS398, MAFP, LY-294002. PD98059 and JNK inhibitor were purchased from Calbiochem Co., and the other compounds were purchased from the Sigma Chemical Co. (San Diego, CA, USA).

Statistical analysis
--------------------

Data are expressed as the means ± standard errors. Differences in the data were evaluated by the Student^'^s t-test. A *P* values less than 0.05 were taken as a statistically significant difference.

The *n* values reported in the text refer to the number of cells used in the patch-clamp experiments.

Results
=======

Effects of H~2~O~2~ on the pacemaker activity in ICC
----------------------------------------------------

To determine whether H~2~O~2~ have function on pacemaker activities of ICC, we recorded the pacemaker potential in a current clamp and pacemaker currents in a voltage clamp. Under the current clamp mode, H~2~O~2~ (1 mM) produced membrane hyperpolarization and decreased the amplitude of the pacemaker potential ([Fig. 1A](#fig01){ref-type="fig"}). Under control conditions at *I*= 0, the resting membrane potential was −52 ± 4.8 mV, and the amplitude of the pacemaker potential was 39.6 ± 5 mV. In the presence of H~2~O~2~, the membrane was hyperpolarized to −76.3 ± 8.0 mV and the amplitude of the pacemaker potentials decreased to 7.6 ± 3.9 mV (*n*= 6, data not shown). Under a voltage clamp at a holding potential of −70 mV, the ICC generated spontaneous inward currents. The mean frequency of these pacemaker currents was 13.9 ± 1.4 cycles/min and their mean amplitude and mean resting current levels were −416 ± 42 pA and −26 ± 7 pA, respectively (*n*= 7). The addition of 10 μM H~2~O~2~ slightly reduced the amplitude and frequency of pacemaker currents and slightly increased resting currents in the outward direction ([Fig. 1B](#fig01){ref-type="fig"}). In the presence of 100 μM and 1 mM H~2~O~2~, the pacemaker currents were largely inhibited and the resting currents were increased in the outward direction ([Fig. 1C and D](#fig01){ref-type="fig"}). The inhibitory frequencies and amplitudes with H~2~O~2~ treatment were 5.1 ± 1.8 cycles/min and −90.9 ± 16 pA at a concentration of 100 μM H~2~O~2~ and 2.8 ± 1.4 cycles/min and −24 ± 19 pA at a concentration of 1 mM H~2~O~2~, respectively. The resting current levels were 23 ± 5.9 pA at a concentration of 100 μM H~2~O~2~ and 24.5 ± 7.2 pA at a concentration of 1 mM H~2~O~2~ (*n*= 7) ([Fig. 1E--G](#fig01){ref-type="fig"}). Next, to determine whether H~2~O~2~ affects K~ATP~ channels in ICC, we used the K~ATP~ channels inhibitor glibenclamide, after or before H~2~O~2~ treatment. The H~2~O~2~-induced effects on pacemaker currents were inhibited by co- or pretreatment with glibenclamide ([Fig. 2A and E](#fig02){ref-type="fig"}), indicating that H~2~O~2~ may activate K~ATP~ channels in ICC. The results of glibenclamide treatment on the H~2~O~2~-induced effects on pacemaker currents are summarized in [Figure 2B--D](#fig02){ref-type="fig"}.

![The effect of H~2~O~2~ on pacemaker potentials and currents in cultured ICC of the murine intestine. (A) Pacemaker potentials of ICC exposed to 1-mM H~2~O~2~ in the current clamping mode (I = 0). (B, C and D) Pacemaker currents of ICC exposed to H~2~O~2~ (10, 100 μM and 1 mM) at a holding potential of −70 mV. (E, F and G) A summarized bar graph showing the H~2~O~2~-induced effects on pacemaker currents of ICC. The bars represent mean ± S.E. values (*n*= 7/group). Asterisks indicate significantly different from the controls (*P* \< 0.05), and the dotted lines indicate zero current levels.](jcmm0014-0257-f1){#fig01}

![The effect of glibenclamide, an inhibitor of ATP-sensitive K^+^ channels, on H~2~O~2~-induced action on pacemaker currents of ICC from the murine intestine. (A) Pacemaker currents exposed to 1 mM H~2~O~2~ at a holding potential of −70 mV. The H~2~O~2~-induced effects were reversed by adding 10 μM glibenclamide. (B, C, and D) The inhibitory response to glibenclamide on the H~2~O~2~-induced action on pacemaker currents. (E) The effect of 1-mM H~2~O~2~ on pacemaker currents after pretreating cells with 10 μM glibenclamide. The bars represent mean ± S.E. values (*n*= 6). Asterisks indicate significantly different from the controls (*P* \< 0.05), and the dotted lines indicate zero current levels. glibenclamide, GBC.](jcmm0014-0257-f2){#fig02}

Effects of catalase and phospolipase A~2~ inhibitors on the H~2~O~2~-induced inhibition of pacemaker currents
-------------------------------------------------------------------------------------------------------------

To evaluate whether the H~2~O~2~-induced inhibition of pacemaker currents was mediated *via* a ROS and PLA~2~ signal pathway, we treated the ICC with catalase (3000 unit/ml), MAFP (10 μM) and AACOCF~3~ (10 μM) before exposure to H~2~O~2~. Catalase inhibited the H~2~O~2~-induced effects ([Fig. 3A](#fig03){ref-type="fig"}) indicating that the H~2~O~2~-induced effects may be an ROS-dependent mechanism. [Figure 3B and C](#fig03){ref-type="fig"} shows that the 1 mM H~2~O~2~-induced effects were significantly inhibited by treatment with MAFP and AACOCF~3~. As shown in [Figure 3C--E](#fig03){ref-type="fig"}, the values of the frequency, amplitude and resting currents by H~2~O~2~ in the presence of catalase, MAFP and AACOCF~3~ were significantly different from those obtained in the absence of catalase, MAFP and AACOCF~3~ (*n*= 5).

![The effect of catalase, a radical scavenger, MAFP, a non-specific phospholipase A~2~ inhibitor, and AACOCF~3~, a cytosolic phospholipase A~2~ inhibitor on the H~2~O~2~-induced action on pacemaker currents of ICC from the murine intestine. (A) The effect of 1 mM H~2~O~2~ on pacemaker currents after pretreating cells with catalase (3000 units/ml). (B) Pacemaker currents exposed to 1 mM H~2~O~2~ after pretreating cells with 10 μM MAFP at a holding potential of −70 mV. (C) The effect of 1 mM H~2~O~2~ on pacemaker currents after pretreating cells with 10 μM AACOCF~3~. (D, E and F) The inhibitory response to catalase, MAFP or AACOCF~3~ on the H~2~O~2~-induced effects on pacemaker currents. The bars represent mean ± S.E. values (*n*= 6). Asterisks indicate significantly different from H~2~O~2~ alone (*P* \< 0.05).](jcmm0014-0257-f3){#fig03}

Involvement of cyclooxygenase and the prostaglandin E~2~ receptor in the H~2~O~2~-induced inhibition of pacemaker currents
--------------------------------------------------------------------------------------------------------------------------

Since activation of the PLA~2~ pathway would stimulate the cyclooxygenase (COX) and prostaglandins synthesis, we examined the role of this system in mediating the H~2~O~2~-induced effects using SC-560 (10 μM), a specific COX-1 inhibitor, or NS-398 (10 μM), a specific COX-2 inhibitor. ICC were pretreated with SC-560 (10 μM) or NS-398 (10 μM) prior to the treatment with H~2~O~2~. We found that the H~2~O~2~-induced effects was inhibited by pretreatment with SC-560 or NS-398 (*n*= 7, [Fig. 4A and B](#fig04){ref-type="fig"}). Our previous report suggested that PGE~2~-activated K~ATP~ channels through PGE-EP~2~ receptor activation in ICC \[[@b20]\]. Therefore, we tested AH6809 (10 μM), a PGE~2~-EP~2~ receptor antagonist and found the H~2~O~2~-induced effects were inhibited by pretreatment with AH6809 ([Fig. 5A](#fig05){ref-type="fig"}). Furthermore, AH6809 inhibited the PGE~2~-induced effects ([Fig. 5B](#fig05){ref-type="fig"}). The values of the frequency, amplitude and resting currents induced by H~2~O~2~ in the presence of AH6809 were significantly different from those obtained in the absence of AH-6809 (*n*= 6, [Fig. 5C--E](#fig05){ref-type="fig"}). These results suggest that PGE~2~ may be involved in the H~2~O~2~-induced inhibition of pacemaker currents.

![The effect of SC-560, a specific cyclooxgenase-1 inhibitor, and NS-398, a specific cyclooxygenase-2 inhibitor, on the H~2~O~2~-induced effects on pacemaker currents of ICC from the murine intestine. (A) Pacemaker currents exposed to 1 mM H~2~O~2~ after pretreating cells with 10 μM SC-560 at a holding potential of −70 mV. (B) The effect of 1 mM H~2~O~2~ on pacemaker currents after pretreating cells with 10 μM NS-398. (C, D and E) The inhibitory response to SC-560 or NS-398 on the H~2~O~2~-induced action on pacemaker currents. The bars represent mean ± S.E. values (*n*= 7). Asterisks indicate significantly different from H~2~O~2~ alone (*P* \< 0.05).](jcmm0014-0257-f4){#fig04}

![The effect of AH6809, a PGE~2~-EP~2~ receptor antagonist, on the H~2~O~2~-induced effects on pacemaker currents of ICC from the murine intestine. (A) The effect of 1 mM H~2~O~2~ on pacemaker currents after pretreating cells with 10 μM AH6809. (B) The effect of 1 μM PGE~2~ on pacemaker currents after pretreating cells with 10 μM AH6809. (C, D and E) The inhibitory response to AH6809 on the H~2~O~2~-induced effects on pacemaker currents. The bars represent mean ± S.E. values (*n*= 6). Asterisks indicate significantly different from H~2~O~2~ alone (*P* \< 0.05).](jcmm0014-0257-f5){#fig05}

Involvement of mitogen-activated protein kinases (MAPKs) in the H~2~O~2~-induced inhibition of pacemaker currents
-----------------------------------------------------------------------------------------------------------------

Since many reports suggested H~2~O~2~ activate MAPKs in many cell types, we investigated whether MAPKs are involved in the H~2~O~2~-induced effects using PD98059, a p44/42 MAPK inhibitor, or SB203580, a p38 MAPK inhibitor, or a JNK (c-jun NH~2~-terminal kinse) inhibitor. [Figure 6A](#fig06){ref-type="fig"} shows that PD98059 (10 μM) prevented the H~2~O~2~-induced effects. However, SB203580 and JNK inhibitor did not affect the H~2~O~2~-induced effects ([Fig. 6B and C](#fig06){ref-type="fig"}). The values of the frequency, amplitude and resting currents by H~2~O~2~ in the presence of PD98059 were significantly different from those obtained in the absence of PD98059 (*n*= 6, [Fig. 6E--G](#fig06){ref-type="fig"}). In addition, PD98059 inhibited the PGE~2~-induced effects; supporting the role of PGE~2~ as a mediator of H~2~O~2~ ([Fig. 6D](#fig06){ref-type="fig"}).

![The effect of PD98059, SB203580 and the JNK inhibitor on the H~2~O~2~-induced effects on pacemaker currents of ICC from the murine intestine. (A) The effect of 1 mM H~2~O~2~ on pacemaker currents after pretreating cells with 10 μM PD98059, a p44/42 MAPK inhibitor, for 15 min. (B) The effect of 1 mM H~2~O~2~ on pacemaker currents after pretreating cells with 10 μM SB203580, a p38 MAPK inhibitor, for 15 min. (C) The effect of 1 mM H~2~O~2~ on pacemaker currents after pretreating cells with 10 μM JNK inhibitor, c-jun NH~2~-terminal kinase inhibitor, for 15 min. (D) The effect of 1 μM PGE~2~ on pacemaker currents after pretreating cells with 10 μM PD98059 for 15 min. (E, F, and G) The inhibitory response to PD98059 on the H~2~O~2~-induced action on pacemaker currents. The bars represent mean ± S.E. values (*n*= 6/group). Asterisks indicate significantly different from H~2~O~2~ alone (*P* \< 0.05), and the dotted lines indicate zero current levels. PD98059, PD; SB203580, SB; JNK inhibitor, JNK.](jcmm0014-0257-f6){#fig06}

Effects of the adenylate cyclase inhibitor, PI3-kinase inhibitor and protein kinase C inhibitor in the H~2~O~2~-induced inhibition of pacemaker currents
--------------------------------------------------------------------------------------------------------------------------------------------------------

To determine an upstream regulator of p44/42 activation, ICC were pretreated with either 10 μM SQ-22536 (an adenylate cyclase inhibitor), 10 μM LY-294002 (a PI3-kinase inhibitor) and 0.1 μM calphostin C (a PKC inhibitor). We found that all inhibitors did not affect the H~2~O~2~-induced effects (*n*= 5: bar graph not shown), indicating that the H~2~O~2~-induced effects in ICC are part of a cAMP-, PI3-kinase- and PKC-independent pathway ([Fig. 7A--C](#fig07){ref-type="fig"}).

![The effect of SQ-22536, calphostin C, LY-294002 and AG1478 on the H~2~O~2~-induced effects on pacemaker currents of ICC and images from the ICC expressing the tyrosine kinase fusion protein, delivered by an adenoviral vector from the murine intestine. (A) The effect of 1 mM H~2~O~2~ on pacemaker currents after pretreating cells with 10 μM SQ22536, an adenylate cyclase inhibitor, for 10 min. (B) The effect of 1 mM H~2~O~2~ on pacemaker currents after pretreating cells with 0.1 μM calphostin C, protein kinase C inhibitor, for 10 min. (C) The effect of 1 mM H~2~O~2~ on pacemaker currents after pretreating cells with 10 μM LY-294002, PI3-kinase inhibitor, for 15 min. (D) In resting cells: a punctuate pattern of fluorescence is observed. (E) When ICC are treated with 1 mM H~2~O~2~ for 30 min., the ICC becomes diffuse. (F) The effect of 1 mM H~2~O~2~ on pacemaker currents after pretreating cells with 10 μM AG1478, a potent and selective inhibitor of epidermal growth factor receptor, for 15 min. (G) The effect of 1 μM PGE~2~ on pacemaker currents after pretreating cells with 10 μM AG1478. The dotted lines indicate zero current levels.](jcmm0014-0257-f7){#fig07}

Involvement of EGFR (epidermal growth factor receptor) tyrosine kinase in the H~2~O~2~-induced inhibition of pacemaker currents
-------------------------------------------------------------------------------------------------------------------------------

To evaluate the role of tyrosine kinase in the H~2~O~2~-induced effects, ICC were infected with adenovirus that was constructed containing a tyrosine kinase gene. In [Figure 7D](#fig07){ref-type="fig"}, we could see the tyrosine kinase domain was located predominantly in the nucleus of ICC. When ICC were treated with H~2~O~2~ (1 mM) for 30 min, there was a translocation of the tyrosine kinase from nucleus to the cytosol ([Fig. 7E](#fig07){ref-type="fig"}). This finding indicates that H~2~O~2~ stimulates the tyrosine kinase activity in ICC. Furthermore, to determine whether the H~2~O~2~-induced inhibition of pacemaker currents is mediated by EGFR tyrosine kinase, we treated the cells with AG 1478, a potent and selective inhibitor of EGFR tyrosine kinase. AG 1478 (10 μM) inhibited the H~2~O~2~-induced effects ([Fig. 7F](#fig07){ref-type="fig"}). Also, we found that AG 1478 inhibited the PGE~2~-induced inhibition of pacemaker currents ([Fig. 7G](#fig07){ref-type="fig"}). This finding suggests that the H~2~O~2~-induced effect is dependent on EGFR tyrosine kinase activation through PGE~2~.

Discussion
==========

In the present study, we first demonstrated that H~2~O~2~ induces hyperpolarization of the membrane and inhibits pacemaker currents in intestinal ICC. These effects are mediated through activation of K~ATP~ channels by COX-dependent PGE~2~ production, and receptor tyrosine and MAP kinase are involved in the H~2~O~2~-induced process.

K^+^ channels play an important role in regulating cellular excitability in various cell types. H~2~O~2~ hyperpolarizes the resting membrane potential through the activation of several K^+^ channels in vascular and visceral smooth muscles \[[@b21], [@b22]\]. The activation of K~ATP~ channels would lead to membrane hyperpolarization, which is thought to be an important mechanism for smooth muscle relaxation. We have already functionally reported that ICC have an K~ATP~ channels and that the ICC are modulated by bile salts and antidepressants \[[@b23], [@b24]\]. Deoxycholic acid inhibited pacemaker currents that were blocked by glibenclamide, an inhibitor of the K~ATP~ channel, and imipramine blocked the pinacidil (an opener of the K~ATP~ channels)-induced inhibition in a similar manner as glibenclamide. K~ATP~ channels is comprised of Kir 6.2 with SUR2B in cultured ICC of the mouse \[[@b20]\], indicating these channels may play an important role in the electrical activities of ICC and be a target of endogenous substances and drugs, as in smooth muscle. In the present study, H~2~O~2~ hyperpolarized the membrane potential and inhibited pacemaker currents. These effects were inhibited by glibenclamide, which indicates that H~2~O~2~ can change pacemaker activities through the activation of K~ATP~ channels in ICC.

H~2~O~2~ mediates the production of PGs from arachidonic acid *via* COX enzyme activation in GI tract. For examples, exposure to H~2~O~2~ causes damage to the plasma membrane of the gallbladder muscle and contraction through the generation of PGE~2~ by the cPLA~2~-cyclooxygenase pathway \[[@b25]\]. H~2~O~2~ reduces the lower esophageal sphincter (LES) tone in human esophagitis and the cat LES tone by increasing the synthesis of COX-2 and PGE~2~\[[@b10], [@b26]\]. And we reported that deoxycholic acid activated COX-2-dependent PGE~2~ production \[[@b23]\]. The biological effects of PGE~2~ are mediated *via* four different receptor subtypes (EP1, -2, -3 and -4) \[[@b27]\]. We found that PGE~2~ action on pacemaker currents in ICC was mediated by EP2 receptors and the expression of the EP2 subtype was only detected \[[@b20]\]. In the present study, H~2~O~2~-induced effects were blocked by cPLA~2~ inhibitors (MAFP and AACOCF~3~) or COX inhibitors (SC560 and NS-398) as well as by an EP2-receptor antagonist (AH6809). Taken together, these results suggest that the inhibition of pacemaker currents through activation of K~ATP~ channels by H~2~O~2~ is mediated by cPLA~2~-COX-dependent PGE~2~ production.

A remaining issue to consider is the determination of the signal linkage between production of PGE~2~ by H~2~O~2~ and the activation of K~ATP~ channels. The MAPKs signaling pathway plays an important role in the mediation of cellular responses including visceral smooth muscle contraction \[[@b28]\]. Three principal MAPKs are expressed in various tissues: p44/42 MAPK, JNK and p38 MAPK \[[@b29]\]. H~2~O~2~ and PGE~2~ activate MAPKs in many cell types \[[@b30]--[@b32]\]. In the present study, PD98059, an inhibitor of p44/42 MAPK, inhibited the H~2~O~2~- or PGE~2~-induced inhibition of pacemaker currents suggesting p44/42 MAPK may be involved in the modulation of pacemaker currents by H~2~O~2~. It has been reported that H~2~O~2~ induced ERK1/2 activation in cultured feline ileal smooth muscle cells and pulmonary arterial smooth muscle cells \[[@b32], [@b33]\]. In addition, MAPK-ERK is involved in the activation of K~ATP~ channel by nitric oxide in neurons \[[@b34]\]. In addition, PGE~2~ activates ERK1/2 in several cells \[[@b35], [@b36]\], which supports our results.

cAMP, PI3-kinase, PKC and tyrosine kinase are upstream regulators in MAPKs activation \[[@b22], [@b37]\]. The cAMP pathway is the major inhibitory mechanism responsible for the relaxation of gastrointestinal smooth muscle \[[@b38]\]. In addition, K~ATP~ channels are opened by the cAMP-dependent signal pathway in smooth muscle cells \[[@b39]\]. However, in the current study, treatment with an adenylate cyclase inhibitor had no influence on the H~2~O~2~-induced effects. Also, cell permeable 8-bromo-cAMP did not inhibit pacemaker currents \[[@b40]\], indicating cAMP is not involved in the H~2~O~2~-induced effects. An antagonist of PI3-kinase, LY-294002 suppresses H~2~O~2~-induced contraction in vascular smooth muscle cells \[[@b41]\]. PI3-kinase also has been reported to mediate ERK1/2 activation by insulin and thrombin \[[@b42], [@b43]\]. PI3 kinase leads to activation of PKC \[[@b44]\]. In addition, H~2~O~2~ has been reported to stimulate PKC activities \[[@b45]\]. Also, some reports suggested that spontaneous rhythmic contractions of uterus and intestine were inhibited by a novel and potent inhibitor of c-Kit tyrosine kinase \[[@b46], [@b47]\]. In this study, LY-294002 or PKC blocker (calphostin C) did not affect H~2~O~2~-induced effects. Generally PKC activation produces smooth muscle contraction. Therefore, these results suggest that cAMP, PI3-kinase and PKC are not involved in the H~2~O~2~-signal pathways, indicating that other mechanisms may be involved in the activation of K~ATP~ channels in intestinal ICC by H~2~O~2~.

H~2~O~2~ increases tyrosine phosphorylation of proteins in different cell types \[[@b32]\]. Receptor tyrosine kinase, such as platelet-derived growth factor receptor (PDGFR), epidermal growth factor receptor (EGFR) and insulin-like growth factor (IGFR), have been demonstrated to be targets of ROS \[[@b48], [@b49]\]. It has been reported that H~2~O~2~-induced p44/42 activation was mediated by the receptor tyrosine kinase of EGFR in feline ileal smooth muscle cells and vascular smooth muscle cells \[[@b32], [@b33]\]. Based on these findings, we examined the activation of EGFR using an EGFR antagonist (AG1478) before exposure to H~2~O~2~. We found that EGFR antagonist inhibited the H~2~O~2~-induced effects. It has been reported that PGE~2~ induced EGRF transactivation, leading to the promotion of gastrointestinal cancer cell growth \[[@b35]\]. Furthermore, the PGE~2~ receptor EP4 agonist promotes hepatocytes proliferation through EGFR and ERK phosphorylation \[[@b50]\]. In the present study, an EGFR receptor tyrosine kinase inhibitor inhibited PGE~2~-induced effects. Taken together these findings suggest that the activation of EGFR by H~2~O~2~ *via* PGE~2~ may involve the regulation of pacemaker currents.

In conclusion, we have demonstrated that the inhibition of pacemaker currents by H~2~O~2~ in cultured ICC has mediated the activation of COX, with a consequent increase of PGE~2~ production. And we have showed that during these events, the increasing of PGE~2~ can influence on K~ATP~ channels, the receptor tyrosine kinase of EGFR and also MAPK (p44/42) pathway.
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